0 CHECKOUT

PRODUCT FILTERS

REGION

21
20
20
20
4

COUNTRY

CATEGORIES

  • 11
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

11
12
18
36

PUBLISHED

0
8
12
36

PRODUCT TYPE

22
9
3
2

Search for: "China Company Research - Jiangsu Hengrui Medicine Co., Ltd "

Investigation Report on China's Atracurium Market, 2010-2019

According to the Chinese government’s statistics, the number of hospitalized cases rose from 115 million in 2008 to 192 million in 2013 with CAGR exceeding 8%, among of which a quarter has to receive...

Published:  August 2015
Price:  From

Investigation Report on China's Atracurium Market, 2010-2019 (Chinese Version)

According to the Chinese government’s statistics, the number of hospitalized cases rose from 115 million in 2008 to 192 million in 2013 with CAGR exceeding 8%, among of which a quarter has to receive...

Published:  August 2015
Price:  From

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review

Jiangsu Hengrui Medicine Co., Ltd. (600276) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has...

Published:  July 2016
Price:  From

Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019

Tegafur, gimeracil and oteracil (Tegafur/gimeracil/oteracil), a fluorouracil derivative, is an oral biological anti- cancer agent made up of tegafur (FT), gimeracil (CDHP) and oteracil (Oxo). In 1999,...

Published:  June 2015
Price:  From

Investigation Report on China Tegafur, Gimeracil and Oteracil (Tegafur/gimeracil/oteracil) Market, 2010-2019 (Chinese Version)

Tegafur, gimeracil and oteracil (Tegafur/gimeracil/oteracil), a fluorouracil derivative, is an oral biological anti-cancer agent made up of tegafur (FT), gimeracil (CDHP) and oteracil (Oxo). In 1999,...

Published:  June 2015
Price:  From

Investigation Report on China's Raloxifene Market, 2010-2019

According to the statistics, over 200 million people suffer from osteoporosis in the world. Among women aged 50 and above in China, 50% have low bone mass or osteoporosis while this figure is 30%-50%...

Published:  June 2015
Price:  From

Investigation Report on China's Raloxifene Market, 2010-2019 (Chinese Version)

According to the statistics, over 200 million people suffer from osteoporosis in the world. Among women aged 50 and above in China, 50% have low bone mass or osteoporosis while this figure is 30%-50%...

Published:  June 2015
Price:  From

Investigation Report on China Tropisetron Market, 2010-2019

Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may...

Published:  June 2015
Price:  From

Investigation Report on China Tropisetron Market, 2010-2019 (Chinese Version)

Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may...

Published:  June 2015
Price:  From

Research Report on Top 50 Companies of China's Pharmaceutical Industry, 2011-2012

" Since 2006, the proportion of China pharmaceutical industry output in GDP has remained stable In the past five years, the proportion fell slightly in 2007, while in other years it kept a growth trend...

Published:  November 2011
Price:  From

Jiangsu Hengrui Medicine Co., Ltd.

A textual analysis of the financial results for Jiangsu Hengrui Medicine Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive...

Published:  July 2016
Price:  From

Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014 (Chinese Version)

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development....

Published:  January 2014
Price:  From

Research and Development Forecast of China Contrast Media (Contrast Agent) Market, 2014

With the mushroom growth of world diagnostic imaging equipments and apparatuses, as for X-CT contrast media, iodinated contrast media serving as the main one is witnessing unprecedented development....

Published:  January 2014
Price:  From

Lymphoma Treatment Drugs Companies in China

This study focuses on China’s Lymphoma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of...

Published:  May 2016
Price:  From

Research Report on Chinese Chemical Pharmaceutical Industry 2010-2011

In China, the chemical pharmaceutical industry includes the chemical API industry and the chemical preparation industry The chemical active pharmaceutical ingredients (API) manufacture refers to the...

Published:  October 2010
Price:  From

Lymphoma Treatment Drugs Markets in China

China's demand for Lymphoma Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed...

Published:  May 2016
Price:  From

Research Report on Top 100 Enterprises in Chinese Pharmaceutical Industry, 2009-2010

In 2008, the sales of Chinese pharmaceutical industry amounted to RMB 677 776 billion, rising by over 20% YOY Among the sub-industries, the sales growth rate of the biological product industry was 31...

Published:  December 2009
Price:  From

Anesthetic Effect - Pipeline Review, H1 2015

‘Anesthetic Effect - Pipeline Review, H1 2015’, provides an overview of the Anesthetic Effect’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development...

Published:  April 2015
Price:  From

Hypertension - Pipeline Review, H2 2015

Hypertension - Pipeline Review, H2 2015 Summary The report ‘Hypertension - Pipeline Review, H2 2015’, provides an overview of the Hypertension’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture

China In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture Summary Our...

Published:  October 2015
Price:  From
Loading Indicator

Our Clients

  • Symantec Corporation
  • Sonoco Products Company
  • Tiffany & Co.
  • ITT Corporation
  • Exxon Mobil Corp.
  • Samsonite International S.A.
  • Kellogg's Co.